SI1628652T1 - Kombinacija analeptičnega modafinila in antidepresiva za zdravljenje depresije - Google Patents
Kombinacija analeptičnega modafinila in antidepresiva za zdravljenje depresijeInfo
- Publication number
- SI1628652T1 SI1628652T1 SI200431933T SI200431933T SI1628652T1 SI 1628652 T1 SI1628652 T1 SI 1628652T1 SI 200431933 T SI200431933 T SI 200431933T SI 200431933 T SI200431933 T SI 200431933T SI 1628652 T1 SI1628652 T1 SI 1628652T1
- Authority
- SI
- Slovenia
- Prior art keywords
- antidepressant
- depression
- treatment
- combination
- analeptic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46994303P | 2003-05-13 | 2003-05-13 | |
US10/844,187 US20040229942A1 (en) | 2003-05-13 | 2004-05-12 | Analeptic and antidepressant combinations |
PCT/US2004/015194 WO2004100937A1 (en) | 2003-05-13 | 2004-05-13 | Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
EP04761006A EP1628652B1 (en) | 2003-05-13 | 2004-05-13 | Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1628652T1 true SI1628652T1 (sl) | 2012-11-30 |
Family
ID=33423928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200431933T SI1628652T1 (sl) | 2003-05-13 | 2004-05-13 | Kombinacija analeptičnega modafinila in antidepresiva za zdravljenje depresije |
Country Status (25)
Country | Link |
---|---|
US (1) | US20040229942A1 (sl) |
EP (1) | EP1628652B1 (sl) |
JP (1) | JP5553955B2 (sl) |
KR (1) | KR20060019537A (sl) |
AR (1) | AR045423A1 (sl) |
AU (1) | AU2004238379B2 (sl) |
BR (1) | BRPI0411174A (sl) |
CA (1) | CA2525524C (sl) |
CY (1) | CY1113154T1 (sl) |
DK (1) | DK1628652T3 (sl) |
EA (1) | EA012173B1 (sl) |
ES (1) | ES2390225T3 (sl) |
HK (1) | HK1087645A1 (sl) |
HR (1) | HRP20120713T1 (sl) |
IS (1) | IS8097A (sl) |
MX (1) | MXPA05012144A (sl) |
MY (1) | MY140179A (sl) |
NO (1) | NO334448B1 (sl) |
NZ (1) | NZ544135A (sl) |
PL (1) | PL1628652T3 (sl) |
PT (1) | PT1628652E (sl) |
SI (1) | SI1628652T1 (sl) |
TW (1) | TWI409061B (sl) |
UA (1) | UA89753C2 (sl) |
WO (1) | WO2004100937A1 (sl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1787980B1 (en) * | 2000-07-27 | 2009-12-30 | Teva Pharmaceutical Industries Ltd. | Crystalline and pure modafinil, and process of preparing the same |
US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
US20040242698A1 (en) * | 2003-05-13 | 2004-12-02 | Cephalon Inc. | Analeptic and antidepressant combinations |
US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
US20090123545A1 (en) * | 2005-07-21 | 2009-05-14 | Ron Eyal S | Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof |
WO2008021341A2 (en) * | 2006-08-14 | 2008-02-21 | Neurohealing Pharmaceuticals, Inc. | Modafinil-based treatment for premature ejaculation |
JP6614014B2 (ja) * | 2016-04-26 | 2019-12-04 | 信越化学工業株式会社 | 含窒素オルガノキシシラン化合物およびその製造方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
FR2663225B1 (fr) * | 1990-06-14 | 1994-11-04 | Lafon Labor | Nouvelle utilisation du modafinil. |
FR2684875B1 (fr) * | 1991-12-13 | 1995-05-24 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique. |
FR2697162B1 (fr) * | 1992-10-23 | 1995-01-13 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux. |
FR2706767B1 (sl) * | 1993-06-22 | 1995-09-08 | Lafon Labor | |
US5933841A (en) * | 1996-05-17 | 1999-08-03 | Ameritech Corporation | Structured document browser |
US5890172A (en) * | 1996-10-08 | 1999-03-30 | Tenretni Dynamics, Inc. | Method and apparatus for retrieving data from a network using location identifiers |
FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
US6359635B1 (en) * | 1999-02-03 | 2002-03-19 | Cary D. Perttunen | Methods, articles and apparatus for visibly representing information and for providing an input interface |
US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
US6455588B1 (en) * | 1999-08-20 | 2002-09-24 | Cephalon, Inc. | Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
WO2001013921A1 (en) * | 1999-08-23 | 2001-03-01 | Ockert David M | Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms |
US20010034373A1 (en) * | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
US6417184B1 (en) * | 2000-09-19 | 2002-07-09 | David M. Ockert | Triple drug therapy for the treatment and prevention of acute or chronic pain |
US20030036555A1 (en) * | 2001-08-03 | 2003-02-20 | Boehringer Ingelheim Pharma Kg | Pramipexole for the treatment of ADHD |
AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
US20040242698A1 (en) * | 2003-05-13 | 2004-12-02 | Cephalon Inc. | Analeptic and antidepressant combinations |
US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
-
2004
- 2004-05-11 AR ARP040101623A patent/AR045423A1/es unknown
- 2004-05-12 US US10/844,187 patent/US20040229942A1/en not_active Abandoned
- 2004-05-13 TW TW093113421A patent/TWI409061B/zh not_active IP Right Cessation
- 2004-05-13 ES ES04761006T patent/ES2390225T3/es not_active Expired - Lifetime
- 2004-05-13 MX MXPA05012144A patent/MXPA05012144A/es active IP Right Grant
- 2004-05-13 CA CA2525524A patent/CA2525524C/en not_active Expired - Fee Related
- 2004-05-13 AU AU2004238379A patent/AU2004238379B2/en not_active Ceased
- 2004-05-13 KR KR1020057021553A patent/KR20060019537A/ko not_active Application Discontinuation
- 2004-05-13 DK DK04761006.8T patent/DK1628652T3/da active
- 2004-05-13 EP EP04761006A patent/EP1628652B1/en not_active Expired - Lifetime
- 2004-05-13 EA EA200501802A patent/EA012173B1/ru not_active IP Right Cessation
- 2004-05-13 NZ NZ544135A patent/NZ544135A/en not_active IP Right Cessation
- 2004-05-13 UA UAA200511839A patent/UA89753C2/ru unknown
- 2004-05-13 BR BRPI0411174-5A patent/BRPI0411174A/pt not_active IP Right Cessation
- 2004-05-13 WO PCT/US2004/015194 patent/WO2004100937A1/en active Search and Examination
- 2004-05-13 MY MYPI20041788A patent/MY140179A/en unknown
- 2004-05-13 PT PT04761006T patent/PT1628652E/pt unknown
- 2004-05-13 PL PL04761006T patent/PL1628652T3/pl unknown
- 2004-05-13 SI SI200431933T patent/SI1628652T1/sl unknown
- 2004-05-13 JP JP2006533080A patent/JP5553955B2/ja not_active Expired - Lifetime
-
2005
- 2005-10-27 IS IS8097A patent/IS8097A/is unknown
- 2005-11-17 NO NO20055450A patent/NO334448B1/no not_active IP Right Cessation
-
2006
- 2006-08-31 HK HK06109734.6A patent/HK1087645A1/xx not_active IP Right Cessation
-
2012
- 2012-09-07 HR HRP20120713TT patent/HRP20120713T1/hr unknown
- 2012-09-28 CY CY20121100892T patent/CY1113154T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
TW200500063A (en) | 2005-01-01 |
BRPI0411174A (pt) | 2006-07-18 |
ES2390225T3 (es) | 2012-11-07 |
EA012173B1 (ru) | 2009-08-28 |
MY140179A (en) | 2009-11-30 |
US20040229942A1 (en) | 2004-11-18 |
CY1113154T1 (el) | 2016-04-13 |
CA2525524A1 (en) | 2004-11-25 |
WO2004100937B1 (en) | 2006-12-21 |
NO334448B1 (no) | 2014-03-03 |
DK1628652T3 (da) | 2012-10-08 |
MXPA05012144A (es) | 2006-02-08 |
PT1628652E (pt) | 2012-09-28 |
UA89753C2 (ru) | 2010-03-10 |
EA200501802A1 (ru) | 2006-06-30 |
WO2004100937A1 (en) | 2004-11-25 |
AR045423A1 (es) | 2005-10-26 |
IS8097A (is) | 2005-10-27 |
NO20055450L (no) | 2006-02-01 |
TWI409061B (zh) | 2013-09-21 |
EP1628652B1 (en) | 2012-07-11 |
AU2004238379B2 (en) | 2009-08-20 |
JP5553955B2 (ja) | 2014-07-23 |
HK1087645A1 (en) | 2006-10-20 |
AU2004238379A1 (en) | 2004-11-25 |
JP2007505156A (ja) | 2007-03-08 |
EP1628652A1 (en) | 2006-03-01 |
HRP20120713T1 (hr) | 2012-09-30 |
NZ544135A (en) | 2008-09-26 |
KR20060019537A (ko) | 2006-03-03 |
CA2525524C (en) | 2012-09-25 |
NO20055450D0 (no) | 2005-11-17 |
PL1628652T3 (pl) | 2012-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1087645A1 (en) | Combination of the analeptic modafinil and an antidepressant for the treatment of depression | |
NO20055448D0 (no) | Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon | |
EP1578719A4 (en) | P-HYDROXY-MILNACIPRAN STEREOISOMERS AND METHODS OF USING THE SAME | |
AP2004003192A0 (en) | Combination of azelastine and steroids. | |
EP1539799A4 (en) | Cross-linked compounds and method for their preparation and use | |
IL173909A0 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
PL381765A1 (pl) | Konstrukty wiążące i sposoby ich zastosowania | |
IL167832A (en) | Sesquiterpene synthases and methods of use | |
AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
EP1546112A4 (en) | IMIDAZOLOPYRIDINE AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2003207698A8 (en) | Needle-suture combinations and methods of use | |
EP1648422A4 (en) | TREATMENT AND PREVENTION OF CARDIOVASCULAR ACCIDENTS | |
EP1476150A4 (en) | CARBOXY FULLERES AND USE METHOD THEREFOR | |
AU2003275056A8 (en) | Novel lapacho compounds and methods of use thereof | |
PL1653982T3 (pl) | Leczenie halitozy | |
GB0324523D0 (en) | Compositions and methods of treatment | |
AU2003216354A8 (en) | Modulators of paraptosis and related methods | |
ZA200510097B (en) | Combination of the analeptic modafinil and an antidepressant for the treatment of depression | |
GB0217493D0 (en) | Novel methods of treatment | |
GB2392746B (en) | Comparison of molecules using field points | |
EP1602723A4 (en) | METHOD FOR THE STUDY OF OBESITY AND EXCEPTION | |
AU2003259689A1 (en) | 3-imino-2-indolones for the treatment of depression and/or anxiety | |
GB0221712D0 (en) | Methods of treatment | |
GB0327975D0 (en) | Methods of treatment |